Literature DB >> 19728518

Cutaneous manifestations of cancer and chemotherapy.

Emma Topham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19728518      PMCID： PMC4952512          DOI： 10.7861/clinmedicine.9-4-375

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  14 in total

Review 1.  Mammary and extramammary Paget's disease.

Authors:  J Kanitakis
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-05       Impact factor: 6.166

Review 2.  Chemotherapeutic agents and the skin: An update.

Authors:  Noushin Heidary; Haley Naik; Susan Burgin
Journal:  J Am Acad Dermatol       Date:  2008-04       Impact factor: 11.527

3.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

Review 4.  Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.

Authors:  Anna Liza C Agero; Stephen W Dusza; Cristiane Benvenuto-Andrade; Klaus J Busam; Patricia Myskowski; Allan C Halpern
Journal:  J Am Acad Dermatol       Date:  2006-10       Impact factor: 11.527

Review 5.  Cutaneous side-effects of kinase inhibitors and blocking antibodies.

Authors:  Caroline Robert; Jean-Charles Soria; Alain Spatz; Axel Le Cesne; David Malka; Patricia Pautier; Janine Wechsler; Catherine Lhomme; Bernard Escudier; Valérie Boige; Jean-Pierre Armand; Thierry Le Chevalier
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

Review 6.  Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature.

Authors:  S Akhtar; K K Oza; S A Khan; J Wright
Journal:  J Am Acad Dermatol       Date:  1999-11       Impact factor: 11.527

Review 7.  Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management.

Authors:  Jenny C Hu; Parrish Sadeghi; Lauren C Pinter-Brown; Sharona Yashar; Melvin W Chiu
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

8.  Extramammary Paget's disease: prognosis and relationship to internal malignancy.

Authors:  J J Chanda
Journal:  J Am Acad Dermatol       Date:  1985-12       Impact factor: 11.527

Review 9.  Mucocutaneous reactions to chemotherapy.

Authors:  W S Susser; D L Whitaker-Worth; J M Grant-Kels
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

10.  Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases.

Authors:  N Basset-Seguin; J C Roujeau; R Gherardi; J C Guillaume; J Revuz; R Touraine
Journal:  Arch Dermatol       Date:  1990-05
View more
  1 in total

1.  Investigation of the Mechanism of Impaired Skin Barrier Function in Dogs With Malignant Tumors.

Authors:  Migyeong Geum; Ha-Jung Kim
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.